May 2023 - Transfusion Medicine - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Transfusion Medicine.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 27 - Insights
This week’s Research Roundup highlights a mechanism for preventing asymmetric histone segregation onto replicating DNA strands.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 3 - Insights
This week’s Research Roundup highlights biphenotypic acute leukemia versus myeloid antigen-positive ALL: Clinical relevance of WHO criteria for mixed phenotype acute leukemia.
Mayo Clinic Laboratory and Pathology Research Roundup: Feb. 12 - Insights
This week’s Research Roundup highlights the prediction of oncologic outcomes in Renal cell carcinoma after surgery.
Mayo Clinic Laboratory and pathology research roundup: January 17 - Insights
This week's research roundup features: Exploring gene expression profiles in primary central nervous system vasculitis
Week in Review: April 22 - Insights
Today's highlights include: Study mines cancer genetics to help with targeted treatment, Mayo Clinic to launch staffing tool app to find 'right nurse for the right role', and new blood biomarker may lead to early diagnosis of frontotemporal...
December 2022 - Transfusion Medicine - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Transfusion Medicine.
Pathways Case Studies: January 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for January include the following sub-specialties: bone and soft tissue, cellular...
Diagnostic and companion testing - Insights
Learn more about how diagnostic and companion testing can confirm a prenatal genetic diagnosis.
Effective testing is vitally important for diagnosis, prognosis, and disease management. With more than 90% of the 7,000 identified rare diseases lacking FDA-approved treatment,1 and patients waiting between 8 and 10 years before diagnosis,...